InvestorsHub Logo
Followers 59
Posts 18522
Boards Moderated 0
Alias Born 11/29/2006

Re: None

Friday, 05/07/2021 6:58:21 AM

Friday, May 07, 2021 6:58:21 AM

Post# of 811
$VYNE HC Wainwright & Co. analyst Oren Livnat maintains VYNE Therapeutics with a Buy and lowers the price target from $14 to $11.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VYNE News